Myriad Genetics (NasdaqGS:MYGN) FY Conference Transcript

Myriad Genetics (NasdaqGS:MYGN) FY Conference December 02, 2025 12:00 PM ET Company ParticipantsSam Raha - CEOBen Wheeler - CFOConference Call ParticipantsNone - AnalystSam RahaWe continue to have one of the most relevant products in terms of content. Back just a couple of weeks ago, we updated our MyRisk flagship product. Now with 63 genes, the most relevant genes in NCCN and ASCO guidelines. It has also been about, you know, the reach that we have with customers. Thousands of customers using our MyRisk pr ...